SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-21-030728
Filing Date
2021-03-02
Accepted
2021-03-02 16:09:43
Documents
66
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K tm211107d1_10k.htm 10-K 1009514
2 EXHIBIT 23.1 tm211107d1_ex23-1.htm EX-23.1 2721
3 EXHIBIT 31.1 tm211107d1_ex31-1.htm EX-31.1 9463
4 EXHIBIT 32.1 tm211107d1_ex32-1.htm EX-32.1 4752
  Complete submission text file 0001104659-21-030728.txt   5859816

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rgrx-20201231.xml EX-101.INS 1417553
6 XBRL TAXONOMY EXTENSION SCHEMA rgrx-20201231.xsd EX-101.SCH 48168
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgrx-20201231_cal.xml EX-101.CAL 51646
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgrx-20201231_def.xml EX-101.DEF 124368
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgrx-20201231_lab.xml EX-101.LAB 343330
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgrx-20201231_pre.xml EX-101.PRE 303945
Mailing Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850 301-208-9191
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15070 | Film No.: 21703621
SIC: 2834 Pharmaceutical Preparations